Life Sciences Times

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

October 31, 2024

Ensoma Appoints Accomplished Deal Maker Jon Garen as Chief Corporate Development and Business Officer

October 28, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Most Popular

Kevin Krause named President and CEO of ArrePath

Thomas Manley, M.D. Joins Rondo Therapeutics as Chief Medical Officer to Lead Clinical Development of Rondo Therapeutics’ Bispecific Antibody Programs

Boston Micro Fabrication Opens Lab to Support Testing, Manufacturing and Sales of Zirconia UltraThineer Veneers

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

Recent Comments

EDITOR PICKS

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

Ensoma Appoints Accomplished Deal Maker Jon Garen as Chief Corporate Development and Business Officer

POPULAR POSTS

New England Biolabs Leases 28,000 SF

Immunology biotech firm to relocate from Cambridge to Woburn

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

POPULAR CATEGORY

ABOUT US

FOLLOW US

LATEST ARTICLES

Most Popular

Recent Comments

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

FOLLOW US